The "Human Immunodeficiency Virus (HIV): Epidemiology Forecast to 2033" report has been added to ResearchAndMarkets.com's offering. This report provides an overview of the risk factors, comorbidities, ...
HIV has become a more manageable condition in recent years, but a full cure remains elusive. Now, scientists have found ...
Dr. Maya Green discusses HIV prevention, U=U, and the importance of regular testing, particularly addressing disparities ...
IFLScience on MSN6d
EBC-46 Shows Tremendous Potential To Help Eradicate HIVA new chemical compound has been making a big impression in the fight against cancer in recent years. Now it seems EBC-46, ...
The shutdown of HHS web pages pertaining to HIV, LGBTQ+ health, and adolescent health raises questions about the future of ...
Hosted on MSN12h
MSD commences Phase III trial of DLBCL treatmentMSD began worldwide recruitment for the trial and subjects are currently being enrolled. In the randomised trial, the ...
A compound with the unpresuming designation of EBC-46 has made a splash in recent years for its cancer-fighting prowess. Now ...
HB-500 is a next-generation therapeutic vaccine being developed in collaboration with Gilead Sciences, Inc. (Gilead) as a potential component of ...
Roll Call on MSN10dOpinion
Pause to AIDS funding leaves health experts scramblingHealth analysts say that the pause in funding for international and domestic efforts to halt HIV and AIDS are "unprecedented.
A new study published in the journal of Nature Scientific Reports found that anemia was almost three times as common in women ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback